Elixinol Wellness Financials
E8M Stock | EUR 0.02 0 10.00% |
Elixinol |
Understanding current and past Elixinol Wellness Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elixinol Wellness' financial statements are interrelated, with each one affecting the others. For example, an increase in Elixinol Wellness' assets may result in an increase in income on the income statement.
Elixinol Wellness Stock Summary
Elixinol Wellness competes with Merck, Takeda Pharmaceutical, HANSOH PHARMAC, Guangzhou Baiyunshan, and ASPEN PHARUNADR. Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. ELIXINOL GLOBAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.Instrument | Germany Stock View All |
Exchange | Frankfurt Exchange |
ISIN | AU000000EXL4 |
Business Address | 680 George Street, |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | www.elixinolwellness.com |
Phone | 61 2 4044 4585 |
Currency | EUR - Euro |
You should never invest in Elixinol Wellness without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Elixinol Stock, because this is throwing your money away. Analyzing the key information contained in Elixinol Wellness' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Elixinol Wellness Key Financial Ratios
There are many critical financial ratios that Elixinol Wellness' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Elixinol Wellness reports annually and quarterly.Return On Equity | -0.71 | |||
Return On Asset | -0.33 | |||
Number Of Employees | 16 | |||
Beta | 1.71 | |||
Z Score | 12.0 |
Elixinol Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elixinol Wellness's current stock value. Our valuation model uses many indicators to compare Elixinol Wellness value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elixinol Wellness competition to find correlations between indicators driving Elixinol Wellness's intrinsic value. More Info.Elixinol Wellness Limited is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elixinol Wellness' earnings, one of the primary drivers of an investment's value.Elixinol Wellness Systematic Risk
Elixinol Wellness' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Elixinol Wellness volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Elixinol Wellness correlated with the market. If Beta is less than 0 Elixinol Wellness generally moves in the opposite direction as compared to the market. If Elixinol Wellness Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Elixinol Wellness is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Elixinol Wellness is generally in the same direction as the market. If Beta > 1 Elixinol Wellness moves generally in the same direction as, but more than the movement of the benchmark.
Elixinol Wellness December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Elixinol Wellness help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elixinol Wellness Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elixinol Wellness Limited based on widely used predictive technical indicators. In general, we focus on analyzing Elixinol Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elixinol Wellness's daily price indicators and compare them against related drivers.
Downside Deviation | 37.04 | |||
Information Ratio | 0.1345 | |||
Maximum Drawdown | 384.09 | |||
Value At Risk | (9.09) | |||
Potential Upside | 50.0 |
Complementary Tools for Elixinol Stock analysis
When running Elixinol Wellness' price analysis, check to measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
CEOs Directory Screen CEOs from public companies around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |